跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SII MR VAC - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
SII MR VAC
Approved
STANDARD
SII MR VAC
Serum Institute of India Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
88e5f83015ae7478
Company
Serum Institute of India Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
88e5f83015ae7478
Drug Approval Philippines Name
SII MR VAC
Product Name
SII MR VAC
Registration Number
BR-839
Brand Name
SII MR VAC
Generic Name
Measles and Rubella Vaccine (Live)
Dosage Form
Lyophilized Powder For Injection (S.C.)
Dosage Strength
NLT 1000 CCID50/0.5 mL
Manufacturer
Serum Institute of India Pvt. Ltd.
Importer
Medical Vaccines Online Deliveries
Distributor
Medical Vaccines Online Deliveries
Company Detail Path
/organization/serum-institute-of-india-pvt-ltd
Issuance Date
05 December 2022
Expiry Date
05 December 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
88e5f83015ae7478
Type
Standard
Back to Philippines FDA Approvals